课题基金 / 基金详情

Lipoteichoic acid mediated immune modulation of chronic pain

Lipoteichoic acid mediated immune modulation of chronic pain
脂磷壁酸介导的慢性疼痛的免疫调节
批准号:
9177358
负责人:
PRAVEEN THUMBIKAT
金额:
$35.19万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2020-07-31

项目摘要

项目成果

PRAVEEN THUMBIKAT的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 在美国,前列腺炎每年的门诊就诊量为200万人次,其中包括1%的初诊 护理医生。慢性盆腔疼痛综合征(CPPS)的临床特征是排尿困难和疼痛。 会阴、睾丸、阴茎和耻骨上区域。慢性前列腺炎占所有慢性前列腺炎的90%,但 建立该综合征的启动因素尚不清楚。我们假设细菌分离物来自 前列腺癌,特别是长寿的临床菌株和常驻病例,能够影响前列腺癌。 豁免权。当患有非感染性自身免疫性前列腺炎(实验性自身免疫性前列腺炎)的小鼠 (EAP),注入共生表皮葡萄球菌后,骨盆疼痛迅速改善, 前列腺病原性免疫反应的负性调节。这些结果引出了我们的假设 表皮葡萄球菌LTA(SELTA)诱导共刺激配体表达以抑制效应性T细胞, 激活调节性T细胞,消除肥大细胞脱颗粒,改善盆腔疼痛。我们 为此,提出以下具体目标:1.明确S。 表皮LTA。2.明确TLR在SELTA-介导的免疫调节中的作用。3.评估SELTA 结合型高密度脂蛋白-金纳米颗粒用于治疗骨盆疼痛。拟议的研究将提供一个 从机理上理解SELTA如何抑制盆腔疼痛并将开发新的尖端 用于人体CP/CPPS测试的治疗学。
英文摘要
Summary Prostatitis accounts for 2 million outpatient visits per year in the United States, including 1% of those to primary care physicians. Chronic pelvic pain syndrome (CPPS) is clinically characterized by dysuria and pain in the perineum, testes, penis and suprapubic region. CPPS accounts for 90% of all chronic prostatitis but the initiating factors that establish the syndrome are unknown. We hypothesized that bacterial isolates from the prostate, particularly long--‐lived clinical strains and resident commensals, are capable of influencing prostate immunity. When mice with non--‐infectious autoimmune prostatitis (Experimental autoimmune prostatitis - EAP), were instilled with the commensal S. epidermidis, there was a rapid amelioration of pelvic pain and a negative modulation of the pathogenic immune response in the prostate. These results lead us to hypothesize that S. epidermidis LTA (SELTA) induces expression of co--‐stimulatory ligands to inhibit effector T cells, activate regulatory T cells and abrogate mast cell degranulation, resulting in the amelioration of pelvic pain. We therefore propose the following specific aims: 1. Identifying the mechanism of pain attenuation mediated by S. epidermidis LTA. 2. Defining the role of TLR’s in SELTA--‐mediated immune modulation. 3. Evaluating SELTA conjugatedHDL--‐goldnanoparticles as a therapeutic for pelvic pain. The proposed studies will provide a mechanistic understanding of how SELTA inhibits pelvic pain and will develop novel cutting--‐edge therapeutics for testing in human CP/CPPS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Lipoteichoic acid mediated modulation of chronic pain
Lipoteichoic acid mediated modulation of chronic pain
海外基金